FSFatemeh Shojaeian

Fatemeh Shojaeian

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fatemeh Shojaeian has a total of 88 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Biomimetic Carbon‐Based Nanomaterials: From Design Strategies to Next‐Generation Biosensing and Theranostic Applications

    by Marzieh Ramezani Farani, Ashkan Zandi, Fatemeh Shojaeian, Mingzhen Zhang, Danial Khorsandi, Fariba Mollarasouli, Iraj Alipourfard, Amin Farahani, Yu Jung Choi, Heemin Kang, et al.

    Carbon‐based nanomaterials (CBNs), including graphene oxide (GO), carbon nanospheres (CNSs), carbon nitrides (CNs), carbon nanotubes (CNTs), carbon dots (CDs), nanoporous carbon, and nanocomposites, possess exceptional thermal, mechanical, electrical, and optical properties with highly versatile surface chemistries. Their tunable size, shape, and surface functionalities facilitate strong π–π interactions and semiconductor‐like behavior, enabling efficient light absorption and intimate biomolecular interfacing. These attributes have positioned CBNs as leading candidates in biomedical engineering, inspiring biomimetic designs that integrate organic and inorganic functions within unified architectures. This review highlights recent advances in the use of CBNs for next‐generation biosensing and theranostics. Approaches such as physicochemical engineering, deoxyribonucleic acid (DNA) origami templating, peptide‐ or enzyme‐assisted assembly, polysaccharide anchoring, and lipid modification have enhanced their biocompatibility, selectivity, and catalytic activity. Innovations in fluorescence switching, aptamer–CNT photophysics, and spacer‐controlled energy transfer enable ultra‐sensitive detection of metal ions, metabolites, neurotransmitters, pathogens, drugs, and cancer biomarkers. Furthermore, integrated CBN‐based platforms, including field‐effect transistors and laser‐scribed graphene electrodes, demonstrate capabilities for single‐virus or single‐cell diagnostics and responsive therapeutic intervention. Finally, translational challenges related to scalable synthesis, biosafety, regulatory harmonization, and public acceptance are discussed, and interdisciplinary strategies combining flexible electronics, organ‐on‐chip models, and AI‐guided design to advance clinical translation of CBN‐enabled precision diagnostics and personalized theranostics are proposed.


  • Open Access

    Supplementary Video S7 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids

    by Bernat Navarro-Serer, Maria F. Wissler, Brandi K. Glover, Michael G. Lerner, Harsh H. Oza, Vania Wang, Hidur Knutsdottir, Fatemeh Shojaeian, Kathleen Noller, Saravana Gowtham Baskaran, et al.

    Time-lapse analysis of empty vector modified PDAC organoids in normoxia

  • Open Access

    Figure 4 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids

    by Bernat Navarro-Serer, Maria F. Wissler, Brandi K. Glover, Michael G. Lerner, Harsh H. Oza, Vania Wang, Hidur Knutsdottir, Fatemeh Shojaeian, Kathleen Noller, Saravana Gowtham Baskaran, et al.

    Knockdown of P4HA1 decreases invasion in PDAC PDOs in hypoxia. A, Expression level of P4HA1 measured by qRT-PCR. Fold changes, expressed relative to the modified control samples, represent a mean of three technical replicates with SDs (PDO4 P = 0.0547, t test; PDO6 P = 0.0816, t test). B, Western blot analysis to confirm effectiveness of P4HA1 knockdown in PDO4 and PDO11 compared with the empty vector. C, Representative images of invasive shControl and shP4HA1_2-modified organoids in hypoxia. Scale bars, 100 μm. D, Effect of P4HA1 knockdown on invasion in modified PDO4 and PDO11 organoids. Percent invasion represents a mean of three biological replicates with SDs. Each biological replicate n > 30 organoids. (P = 0.0005 and P < 0.0001, t test). E, Inverse circularity scores of empty vector–modified and P4HA1 knockdown–modified PDO4 (top; n = 41 and n = 27, respectively; P = 0.0079, t test) and PDO11 (down; both n = 40; P < 0.0001, t test) organoids in hypoxia.

  • Open Access

    Supplementary Video S8 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids

    by Bernat Navarro-Serer, Maria F. Wissler, Brandi K. Glover, Michael G. Lerner, Harsh H. Oza, Vania Wang, Hidur Knutsdottir, Fatemeh Shojaeian, Kathleen Noller, Saravana Gowtham Baskaran, et al.

    Time-lapse analysis of P4HA1 overexpression modified PDAC organoids in normoxia

  • Open Access

    Figure 1 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids

    by Bernat Navarro-Serer, Maria F. Wissler, Brandi K. Glover, Michael G. Lerner, Harsh H. Oza, Vania Wang, Hidur Knutsdottir, Fatemeh Shojaeian, Kathleen Noller, Saravana Gowtham Baskaran, et al.

    Hypoxia increases invasion in patient-derived PDAC organoids. A, Schematic of PDAC organoid culture generation, collection, study, and analysis timeline. B, Effect of hypoxia on invasion in PDO1, PDO4, and PDO11 organoids. Percent invasion represents a mean of minimum three biological replicates with SD. Each biological replicate n > 30 organoids (P = 0.015, P = 0.0032, and P = 0.1636, respectively, t test). C, Fold change of PDAC PDO sample invasion in normoxia and hypoxia. D, Representative images of PDO4 invasive organoids in normoxia and hypoxia. Scale bars, 100 μm. E, Inverse circularity scores of normoxic and hypoxic PDO1 (n = 15 and n = 29, respectively; P = 0.0122, t test), PDO4 (both n = 71; P = 0.0025, t test), and PDO11 (n = 44 and n = 54, respectively; P = 0.0024, t test) invasive organoids. F, Expression level of EMT markers (E-cadherin, N-cadherin, vimentin, and SNAIL) in PDO4 measured by qRT-PCR at multiple time points. Fold changes, expressed relative to normoxic control samples, represent a mean of three technical replicates with SD. G, Western blot analysis of EMT markers (fibronectin, E-cadherin, N-cadherin, and vimentin) in PDO4 in normoxia and hypoxia. H, hypoxia; N, normoxia.

  • Open Access

    Figure 3 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids

    by Bernat Navarro-Serer, Maria F. Wissler, Brandi K. Glover, Michael G. Lerner, Harsh H. Oza, Vania Wang, Hidur Knutsdottir, Fatemeh Shojaeian, Kathleen Noller, Saravana Gowtham Baskaran, et al.

    P4HA1 expression is increased in PDAC and is clinically relevant. A, Gene set enrichment analysis showing a correlation between a high P4HA1 expression and the expression of genes in a hypoxia gene signature (P = 3 × 10−20). B, scRNA-seq analysis shows increased expression levels of P4HA1 in human pancreatic tumors compared with normal tissue (P = 9 × 10−16). C, Protein expression of P4HA1 in PDAC using the Clinical Proteomic Tumor Analysis Consortium database, accessed through the University of Alabama at Birmingham Cancer data analysis Portal. D, Kaplan–Meier analysis of patients with PDAC shows increased risk of death associated with a high expression of P4HA1. Plot generated using KMPlot. The median survival time for low expression and high expression cohorts is 72.73 and 18.17 months, respectively (HR = 2.4; 95% confidence interval, 1.42–4.05; P = 0.00077).

  • Open Access

    Supplementary Figure S4 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids

    by Bernat Navarro-Serer, Maria F. Wissler, Brandi K. Glover, Michael G. Lerner, Harsh H. Oza, Vania Wang, Hidur Knutsdottir, Fatemeh Shojaeian, Kathleen Noller, Saravana Gowtham Baskaran, et al.

    Impact of P4HA1 knockdown on organoid invasion in normoxia

  • Open Access

    Supplementary Table S3 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids

    by Bernat Navarro-Serer, Maria F. Wissler, Brandi K. Glover, Michael G. Lerner, Harsh H. Oza, Vania Wang, Hidur Knutsdottir, Fatemeh Shojaeian, Kathleen Noller, Saravana Gowtham Baskaran, et al.

    Differentially expressed genes between normoxic and hypoxic invasive PDAC organoids

  • Open Access

    Supplementary Video S6 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids

    by Bernat Navarro-Serer, Maria F. Wissler, Brandi K. Glover, Michael G. Lerner, Harsh H. Oza, Vania Wang, Hidur Knutsdottir, Fatemeh Shojaeian, Kathleen Noller, Saravana Gowtham Baskaran, et al.

    Time-lapse analysis of P4HA1 knockdown modified PDAC organoids in normoxia

  • Open Access

    Figure 2 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids

    by Bernat Navarro-Serer, Maria F. Wissler, Brandi K. Glover, Michael G. Lerner, Harsh H. Oza, Vania Wang, Hidur Knutsdottir, Fatemeh Shojaeian, Kathleen Noller, Saravana Gowtham Baskaran, et al.

    Comparison of transcriptomes and molecular pathways of invasive normoxic and hypoxic organoids. A, Principal component analysis plot of gene expression in hypoxic invasive organoid samples (n = 8). PC, principal component. B, Volcano plot of differentially expressed genes between normoxic and hypoxic invasive organoids. FC, fold change. C, Pathway analysis of normoxic and hypoxic invasive organoids using KEGG processes. D, Pathway analysis of normoxic and hypoxic invasive organoids using GO Biological Processes (GO-BP). E, IHC for hydroxyproline surrounding invasive and noninvasive organoids in PDO4 and PDO11. F, Western blot analysis assessing P4HA1 levels in 2D cultures prepared from PDO4 and PDO11 organoids 24 hours after treatment with a HIF1a inhibitor (10 μmol/L PX-478). H, hypoxia; N, normoxia.